Bioorthogonal oncolytic-virus nanovesicles combined bio-immunotherapy with CAR-T cell for solid tumors

Biomater. Sci., 2024, Accepted Manuscript
DOI: 10.1039/D4BM01305K, Paper

Open Access

&nbsp This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

Guojun Huang, Yiran He, Xiaocong Chen, Ting Yin, Ai-Qing Ma, Lizhen Zhu, Liqi Chen, Ruijing Liang, Pengfei Zhang, Hong Pan, Lintao Cai
Various oncolytic viruses (OVs) have been adopted as therapeutic tools to increase the efficacy of chimeric antigen receptor (CAR)-T cells against solid tumors. However, the therapeutic effect of Ovs was...
The content of this RSS Feed (c) The Royal Society of Chemistry